Stabinorm botanical mixture for a claimed fatigue use — RU2390348C1
Т. В. Лукашина, Т. А. Сокольская, М. Ф. Минеева, В. К. Колхир, Л. В. Крепкова, А. И. Громакова, Е. В. Валь, К. Ю. Калиниченко, Г. М. Тохтабаева, А. В. Рогов · 2010 · RU2390348C1 · patent family 42680342
Published 2010-05-27.
Reported patent results
Reported findings
Stabinorm at 0.1 mg/kg improved selected rodent endurance and heat-stress measures. Time on the open arm of an elevated plus maze increased threefold at 0.1 mg/kg and twofold at 1 mg/kg.
Rodent groups of 10. The researchers gave the mixture by intragastric administration at 0.1 or 1 mg/kg, usually 30 minutes before testing, and compared with water controls.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Elevated plus maze | Open-arm time was 3-fold control at 0.1 mg/kg and 2-fold control at 1 mg/kg. | |
| Endurance and heat stress | The inventors report improvements in endurance, heat tolerance and rotarod time at 0.1 mg/kg, without numerical effects in the narrative. |
Rodent performance and behavioral endpoints give experimental context for the formulation claim.
Source for these results ↗ · Reviewed 2026-11-12
Patent claims and provenance
Formulation. Five extracts from ginseng, Eleutherococcus, leuzea, nettle and St John’s wort. The patent reports laboratory and animal results.
The disclosure tests rodent endpoints and makes a proposed clinical use claim. It supplies no controlled human ME/CFS results.
- Publication
- RU2390348C1 ↗ · 2010-05-27
- Earliest priority / filing
- 2008-11-14 / 2008-11-14
- Original applicant / assignee
- ФармацентрВИЛАР
- Indexed status
- Not shown; official status unverified · checked 2026-11-12
- Patent family
- 42680342 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Средство «Стабинорм» для лечения синдрома хронической усталости
Inventors: Т. В. Лукашина; Т. А. Сокольская; М. Ф. Минеева; В. К. Колхир; Л. В. Крепкова; А. И. Громакова; Е. В. Валь; К. Ю. Калиниченко; Г. М. Тохтабаева; А. В. Рогов.
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The disclosure tests rodent endpoints and makes a proposed clinical use claim. It supplies no controlled human ME/CFS results.
- Rodent performance and behavioral endpoints give experimental context for the formulation claim.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; each record lists the review date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Available format: Original patent text and indexed metadata
Material reviewed: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related publications may cover the same research program or participants.
Source access
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Source reviewed 2026-11-12.
Source type: Patent publication
Citation and original source
Original source: Т. В. Лукашина, Т. А. Сокольская, М. Ф. Минеева, В. К. Колхир, Л. В. Крепкова, А. И. Громакова, Е. В. Валь, К. Ю. Калиниченко, Г. М. Тохтабаева, А. В. Рогов. Stabinorm botanical mixture for a claimed fatigue use — RU2390348C1 RU2390348C1 · patent family 42680342 2010.
Molekul research summary: https://molekul.io/research/patent-ru2390348c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry